Kv7 channels a potential therapeutic target in fibromyalgia: A hypothesis

LAWSON, Kim (2018). Kv7 channels a potential therapeutic target in fibromyalgia: A hypothesis. World Journal of Pharmacology, 7 (1), 1-9.

[img]
Preview
PDF
Lawson_Kv7_channels(VoR).pdf - Published Version
Creative Commons Attribution Non-commercial.

Download (536kB) | Preview
Link to published version:: https://doi.org/10.5497/wjp.v7.i1.1

Abstract

Fibromyalgia is characterized by the primary symptoms of persistent diffuse pain, fatigue, sleep disturbance and cognitive dysfunction. Persistent pain conditions, such as fibromyalgia, are often refractory to current available therapies. An involvement of K+ channels in the pathophysiology of fibromyalgia is emerging and supported by drug treatments for this condition exhibiting action at these molecular processes. K+ channels constitute potential novel target candidates for pain therapy offering peripheral and/or central actions. The Kv7 channel activators, flupirtine and retigabine, have exhibited pharmacological profiles compatible to the requirements needed for use as a therapeutic approach to fibromyalgia. Clinical trials to address the multidimensional challenges of fibromyalgia with flupirtine and retigabine will provide important insight to the role of K+ channels in this condition.

Item Type: Article
Research Institute, Centre or Group: Biomolecular Sciences Research Centre
Departments: Health and Well-being > Department of Bioscience
Identification Number: https://doi.org/10.5497/wjp.v7.i1.1
SWORD Depositor: Symplectic Elements
Depositing User: Symplectic Elements
Date Deposited: 29 Oct 2018 10:21
Last Modified: 16 Nov 2018 12:05
URI: http://shura.shu.ac.uk/id/eprint/23123

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year

View more statistics